Clinical significance of SARS-CoV-2-specific IgG detection with a rapid antibody kit for COVID-19 patients.
Yong ChongHideyuki IkematsuNaoki TaniYoko ArimizuHaruka WatanabeYukako FukamachiAkiko YonekawaSho IwasakaRuriko NishidaYoshihiro EriguchiNoriko MiyakeShinji ShimodaYoji NagasakiNobuyuki ShimonoKoichi AkashiPublished in: Influenza and other respiratory viruses (2020)
SARS-CoV-2-specific IgG production can be detected in all infected individuals, using a rapid antibody kit, irrespective of clinical status. However, these findings suggest that, in some infected individuals, particularly those with asymptomatic status, the presence of virus-specific IgG antibodies does not imply prompt viral clearance.